Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL4-phCSF2 (#RDB07482)

Promoter collection, Human CSF2 promoter

Alternative name U2815-1
Clone info. PCR amplified human CSF2 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 132072406 to 132073823(NC_000005.10); relatively -1383 to +35, where +1 corresponds to 1 nt of NM_000758.4.
Comment PCR cloning, forward primer: CTCCACCTGCTCTCTGAAGG; reverse primer: CCTCCAGAGAACTTTAGCCTTTCT. Entire sequence of promoter region has not been confirmed.
Vector backbone pGL4.10 [Luc2] (Plasmid)
Selectable markers Amp^r
Gene/insert name Human colony stimulating factor 2 (granulocyte-macrophage) genomic DNA
Depositor|Developer DNA Bank, |
 
Remarks, protocol and/or map (pdf) RDB07482.pdf

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07482 pGL4-phCSF2 DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pGL4-phCSF2 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07482).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07482_A3Hr.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer:
Sequence file: RDB07482_A3Hra.seq check
>07482_07482_A3Hr_pGL4-4174F_G01_19.ab1
    1 GCCGGGGTCA GAACATTTCT CTGGCCTACT GGCCGGTACC TGAGCTCGCT AGCCTCGAGG
   61 ATCTCCACCT GCTCTCTGAA GGCTCGCCAA CCTGAGTCCA GCAGAATGTT CTCGCTTGTG
  121 TCCAACCCCA CTGGTTTAGG CTGAATCAGC CTCTAGGGCC CAGAGGCACT GCACCTGGAG
  181 TAGGGAGCTT CTCCAGTATC AGAGTCACCT TCAGAGGCCT GGAGCCTTTC ATAAAGCAGG
  241 TAAGAGGACT CAATAGATGC ATCTGCATGG AAAACATCCT CCCCTCTACC AGGCACCTGT
  301 ATGTACAACC AATCACAGCA GCACACATAC ACCCAGAAAT GGGCACGTGT GGGCCCACAC
  361 CCCTTTAGCT ATGAAACCCA GGCATGGGGC AGCTTGAGCC AGATACCTTG TGCAAACACA
  421 AACTCGTGCT GTCTTCTCTG AACTCCATTG TGAAAATCAA ACACTTGTCA GCCCCTCAAG
  481 AGCCTTTAGA TTTCCTACTT CCACACTTCC ACAGAAAGGC CTCTGGAGTT GGGGGATGCT
  541 GGGGTTATGT AGGAAATTAA GCCTGGAGGG CCTTGCTGGG GAAGCCATTG TCCCTGTACC
  601 TGAGATGGAT GCAGCCACAG CCCTGGAGCC AGCCTGAAGC TCCTGGTGTC TTCTGGGGGC
661 TACATATAGG AG
//
Primer:
Sequence file: RDB07482_A3Hrb.seq check
>07482_07482_A3Hr_pGL4-136R_H01_22.ab1
    1 GGTCTAATGT TTTTGGCATC TTCCATGGTG GCTTTACCAA CAGTACCGGA TTGCCAAGCT
   61 TGGCCGCCGA GGCCAGATCT TGATCCTCCA GAGAACTTTA GCCTTTCTCT CTGTGTACTG
  121 GGCTCACTGG CAAAAGAGCT CTTAAATACA CAGAGGAAAT GATTAATGGT GACCACAAAA
  181 TGCCAGGGAG GCGGGGGAAC TACCTGAACT GTGGAATCTC CTGGCCCTTA TCAGCCACAC
  241 ATGGGAACGG TGAGCCTTTT CCCTAGGTGG TCAGGCTTGG GGGTTTTCAT TAATGAACCT
  301 TTCCAAGAAC CGACAGCCCA CCCACCCGCC TTCCTGAGGG CTCTCCAGCC CTCCCTGGGC
  361 AGTCTGAATG GGCCTGAGGC TGCCCCCTCC CTCTGAGGGG CACAGTTTGG ACTTCCTGGC
  421 CTGGAATGGC TGGGGTGGGG CGTGGGAGAC ACTTAGATAG GGCTCCCCAT CCTGCCTGTA
  481 ATCCCAGGGG CCTTTGGGCA GGCTATGCCC GCCCTGGTGC CTCATTCTGA CTCCAGCCTT
  541 CCTCTTCTCT GGCCACTGTG AGAGACTTGA GTGTGAGGGG AGCTCTCACA GACCTGCCCC
  601 ACTGACAGTT CACATGGGCT CCCACCCAGG ACCTGGAGCA GGGGGCAACC TCAGTCCAGT
661 AAGGGGGGAC CCCTGCC
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles